May 17, AM. This is just the beginning β we are on a path to advance our mission to reach more patients with innovative medicines across Europe and globally. Founded in , BeiGene now counts a global team of over 8, colleagues across five continents. The company conducts clinical trials globally and to date has enrolled patients from more than 45 countries, including 25 countries in Europe. On the occasion of the opening event, BeiGene hosted several government representatives and business leaders from the region discussing the value of biotechnology leaders like BeiGene to the greater Basel area.
With BeiGene we see opportunities for interesting synergies and exchanges. In addition to the new Basel office, BeiGene has regional offices in Cambridge, Massachusetts and Beijing, China, with a total of 30 office locations around the world. BeiGene Oncology. BeiGene is committed to advancing best- and first-in-class clinical candidates internally or with like-minded partners to develop impactful and affordable medicines for patients across the globe.
Our expansive portfolio is directed predominantly by our internal colleagues supporting clinical trials in more than 45 countries and regions. Hematology-oncology and solid tumor targeted therapies and immuno-oncology are key focus areas for the company, with both mono- and combination therapies prioritized in our research and development.
BeiGene also partners with innovative companies who share our goal of developing therapies to address global health needs. We also plan to address greater areas of unmet need globally through our other collaborations including with Mirati Therapeutics, Seagen, and Zymeworks. Novartis and BeiGene also entered into a strategic commercial agreement through which BeiGene will promote five approved Novartis Oncology products across designated regions of China.
About BeiGene. BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide.
